Articles
| Open Access | RESULTS OF PROPRONALOL TREATMENT OF FACIAL HEMANGIOMAS
Karimov M.A. , Impuls Medical Institute, Namangan Sh., Uzbekistan Kholmirzaev O.N. , Namangan State University Faculty of Medicine, Namangan Sh., Uzbekistan Inomov Q.S. , Andijan State Medical Institute, Andijan Sh., Uzbekistan. Karimkulov N.A. , Andijan State Medical Institute, Andijan Sh., Uzbekistan. Mirzakarimov B.N. , Andijan State Medical Institute, Andijan Sh., Uzbekistan.Abstract
This article describes the clinic, prevalence, modern diagnosis, stages of development, classification and results of drug treatment of hemangioma located in the facial area. In the study, the results of treatment of 120 patients with facial hemangioma were analyzed.
Keywords
Hemangioma, propronalol, dopplerography, medical treatment.
References
Chang L., Y. Gu, Z. Yu [et al.] / When to stop propranolol for infantile hemangioma // Sci. Rep. – 2017. – Vol. 7. – P. 43292. Doi: 10.1038/ srep 43292. Published 2017 Feb 22
Goto, K., Ozeki, M., Yasue, S., Endo, S., & Fukao, T. (2020). A retrospective study of 2 or 3 mg/kg/day propranolol for infantile hemangioma. Pediatr Int, 62(6), 751-753.
Kagami, S. 1. Oral propranolol for infantile hemangiomas beyond the proliferative phase / S. 1. Kagami // J Dermatol. – 2018. – Vol. 45, № 10. – P. 1199–1202. Doi: 10.1111/1346-8138.14581.
Karimov M. A., Nurmatova Kh. H. Results Of Drug Treatment Of Hemangiomas During Infantry. The Journal of Rivista Italiana di Filosofia Analitica Junior 2023. – Vol. 14, № 2. – P. 561–563. https://www.rifanalitica.it/index.php/journal/article/view/262
Karimov M.A. Sadykov R.R., Sadykov R.A., Mahmudov G. Early fluorescence detection of oropharengeal and esophageal cancer. https://doi.org/10.1093/annonc/mdz155.332
Karimov M.A... New approaches in the diagnosis of oral hemangiomas The American Journal of Medical Sciences and Pharmaceutical Research Doi: https://doi.org/10.37547/TAJMSPR/ Volume02Issue08 August 20, 2020| Pages:50-57
Léauté-Labrèze C., Prey S., Ezzedine K. Infantile haemangioma: Part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities. J. Eur. Acad. Dermatol. Venereol. 2011; 25(11): 1245–53. doi: 10.1111/j.14683083.2011.04102.x.
Wassef M., Blei F., Adams D., Alomari A., Baselga E., Berenstein A., et al.; ISSVA Board and Scientific Committee. Vascular Anomalies Classification: Recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics. 2015; 136(1): e203--14. doi: 10.1542/peds.2014-3673.
Коноплицкий Д.В. Классификационный алгоритм лечения гемангиом наружной локализации у детей // Молодий вчений. 2015. 2—6, № 17. С. 618—622.
М. А. Каримов, 1Д. З. Мамарасулова, 2Р. Р. Садиков, 3Х. Х. НурматоваРЕЗУЛЬТАТЫ ЛЕЧЕНИЯ ГЕМАНГИОМ РОТОВОЙ ПОЛОСТИ Доктор ахборотномаси № 4 (97)—2020 с. 162-165
М.А.Каримов, Р.Р.Садиков, Х.Х.Нурматова. (2023). ОҒИЗ БЎШЛИҒИ ГЕМАНГИОМАЛАРИНИ КОМПЛЕКС ДАВОЛАШ НАТИЖАЛАРИ. EURASIAN JOURNAL OF ACADEMIC RESEARCH, 3(4), 102–107. https://doi.org/10.5281/zenodo.7805172
Трапезникова Т.В., Хлебникова А.Н., Писклакова Т.П. Инфантильные гемангиомы: абсолютные показания к лечению. Человек. Спорт. Медицина 2017. Т. 17, № 3. С. 52–60 59
Чижевская, И.Д. Неинвазивный метод лечения врожденных гемангиом челюстнолицевой области у детей / И.Д. Чижевская // Педиатрия. Восточная Европа. – 2015. – № 3. – С. 160–166
Article Statistics
Downloads
Copyright License
This work is licensed under a Creative Commons Attribution 4.0 International License.